ENT Disorder Clinical Trials

69 recruitingLast updated: June 18, 2026

There are 69 actively recruiting ent disorder clinical trials across 23 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Philadelphia, Pennsylvania, United States. Updated daily from ClinicalTrials.gov.


ENT Disorder Trials at a Glance

69 actively recruiting trials for ent disorder are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 34 trials, with the heaviest enrollment activity in Boston, New York, and Philadelphia. Lead sponsors running ent disorder studies include Boston Children's Hospital, National Institute of Neurological Disorders and Stroke (NINDS), and IRCCS Eugenio Medea.

Browse ent disorder trials by phase

Treatments under study

About ENT Disorder Clinical Trials

Looking for clinical trials for ENT Disorder? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ENT Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ENT Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 69 trials

Recruiting

Genetic Characterization of Movement Disorders and Dementias

DementiaMovement Disorder
National Institute on Aging (NIA)12,000 enrolled1 locationNCT02014246
Recruiting

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Movement DisordersParkinson DiseaseDystonia+1 more
Boston Scientific Corporation200 enrolled4 locationsNCT06553625
Recruiting

Botulinum Toxin for the Treatment of Involuntary Movement Disorders

Movement Disorders
National Institute of Neurological Disorders and Stroke (NINDS)2,000 enrolled1 locationNCT00001208
Recruiting

Phenotype/Genotype Correlations in Movement Disorders

Movement Disorder
National Institute of Neurological Disorders and Stroke (NINDS)2,500 enrolled1 locationNCT00018889
Recruiting

Human Movement Database

Movement Disorder
National Institutes of Health Clinical Center (CC)7,500 enrolled1 locationNCT00001252
Recruiting
Phase 2

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Adjustment Disorder
Reunion Neuroscience Inc100 enrolled30 locationsNCT07002034
Recruiting
Not Applicable

Dyadic Mindfulness for People With Parkinson's Disease and Their Caregivers

MindfulnessMovement DisordersCaregivers+4 more
The University of Hong Kong200 enrolled1 locationNCT06821230
Recruiting

Cognitive Decline Following Deep Brain Stimulation

Movement DisordersParkinson Disease
Medical University of South Carolina80 enrolled1 locationNCT05822388
Recruiting
Not Applicable

Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia

Movement DisordersDystoniaCombined Dystonia+1 more
University Hospital, Strasbourg, France150 enrolled4 locationsNCT06999096
Recruiting
Not Applicable

The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intentions Among Patients With Functional Neurological Movement Disorders

Functional Movement DisorderFunctional neurological disorder
Medical University of Graz35 enrolled1 locationNCT07588282
Recruiting
Phase 2

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

CancerAdjustment Disorders
Sunstone Medical20 enrolled1 locationNCT05584826
Recruiting
Not Applicable

Non-invasive BCI-controlled Assistive Devices

Traumatic Brain InjuryHealthyMovement Disorders+6 more
University of Texas at Austin100 enrolled1 locationNCT05183152
Recruiting

Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Water

Movement DisordersEnergy Metabolism
University of Wisconsin, Milwaukee125 enrolled1 locationNCT05736302
Recruiting

Cortical Tracking of Speech in the First Year of Life

Language DevelopmentInfant DevelopmentLanguage Development Disorders+1 more
IRCCS Eugenio Medea50 enrolled1 locationNCT07531706
Recruiting
Not Applicable

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

Malignant Solid NeoplasmCancerHematopoietic and Lymphoid System Neoplasm+3 more
Mayo Clinic24 enrolled1 locationNCT07221409
Recruiting

Natural History Protocol for Movement Disorders

TremorParkinson's DiseaseMovement Disorder
National Institute of Neurological Disorders and Stroke (NINDS)4,000 enrolled1 locationNCT05413291
Recruiting
Not Applicable

Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients

Movement DisordersParkinson's Disease
YangPan50 enrolled1 locationNCT07384442
Recruiting

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

Movement DisordersParkinsons DiseaseNeurology
InSightec60 enrolled5 locationsNCT05539196
Recruiting

A Multicenter Pediatric Deep Brain Stimulation Registry

Movement DisordersNeurologic DisorderCerebral Palsy+6 more
Boston Children's Hospital100 enrolled1 locationNCT06585618
Recruiting

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

Movement DisordersMotor Neuron DiseaseHereditary Spastic Paraplegia+3 more
Boston Children's Hospital200 enrolled1 locationNCT05354622